PodcastIntel
Sign in Get Started Free
The Immune-Mediated Inflammatory Disease Forum
The Immune-Mediated Inflammatory Disease Forum

Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA

Jul 16, 2026 · 0:23:49
Listen to Episode
✨ AI Summary
  • Reviewing top axSpA publications.
  • Discussing long-term safety and efficacy of bimekizumab and ixekizumab.
  • Focus on refractory axial spondyloarthritis (r-axSpA).

Guests on This Episode

AD
Atul Deodhar
researcher · 2 podcast appearances
›
SR
Sofia Ramiro
researcher · 6 podcast appearances
›

More from The Immune-Mediated Inflammatory Disease Forum

The Immune-Mediated Inflammatory Disease Forum
Discussing RA: Impact of BMI on response to JAK inhibitors in RA
Oct 8, 2026 · 0:07:14
The Immune-Mediated Inflammatory Disease Forum
Discussing axSpA: 52-week results from the Phase 3 BE MOBILE trials
Sep 30, 2026 · 0:20:11
The Immune-Mediated Inflammatory Disease Forum
Author Interview: Doctor Elise van Mulligen, September 2026
Sep 3, 2026 · 0:21:21
The Immune-Mediated Inflammatory Disease Forum
Discussing RA: Biologic effectiveness and treatment persistence in RA
Aug 27, 2026 · 0:08:53
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to The Immune-Mediated Inflammatory Disease Forum and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →